Listed

Vaxart, Inc.: Form 10-K for the period ended Jun 30, 2017

Filed with the SEC on Sep 1, 2017 and accepted by EDGAR at Sep 1, 2017, 16:45 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2017-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2016-07-01 to 2017-06-30$8.9mus-gaap:Revenues
Research and development12 months2016-07-01 to 2017-06-30$28.3mus-gaap:ResearchAndDevelopmentExpense
Operating income12 months2016-07-01 to 2017-06-30−$27.5mus-gaap:OperatingIncomeLoss
Income tax12 months2016-07-01 to 2017-06-30$300.0kus-gaap:IncomeTaxExpenseBenefit
Net income12 months2016-07-01 to 2017-06-30−$29.4mus-gaap:NetIncomeLoss
Diluted EPS12 months2016-07-01 to 2017-06-30−$0.76us-gaap:EarningsPerShareDiluted
Basic EPS12 months2016-07-01 to 2017-06-30−$0.76us-gaap:EarningsPerShareBasic
Diluted shares (weighted)12 months2016-07-01 to 2017-06-3038,644,395 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2016-07-01 to 2017-06-30−$30.0mus-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Cash and equivalentsAt period end2017-06-30$17.7mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2017-06-30$39.9mus-gaap:AssetsCurrent
Total assetsAt period end2017-06-30$40.1mus-gaap:Assets
Current liabilitiesAt period end2017-06-30$5.9mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2017-06-30$21.4mus-gaap:Liabilities
Shareholders' equityAt period end2017-06-30$18.7mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001437749-17-015526. Last ingested by Listed: Nov 5, 2026, 18:48 ET. Listed shows no prices and gives no investment advice.